Adicet Bio Inc (ACET)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,857 | -23,450 | -9,859 | -33,770 | -10,724 |
| Depreciation Amortization | 55 | 31 | 9 | 5 | 3 |
| Accounts payable and accrued liabilities | 2,807 | 3,119 | 80 | 1,392 | 1,094 |
| Other Working Capital | 2,090 | 4,806 | 1,365 | 4,260 | 1,902 |
| Other Operating Activity | -900 | -1,593 | 1,101 | 17,133 | 1,729 |
| Operating Cash Flow | $-27,805 | $-17,087 | $-7,304 | $-10,980 | $-5,996 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -92,293 | -74,543 | N/A | N/A | N/A |
| PPE Investments | -333 | -304 | -278 | -40 | -39 |
| Investing Cash Flow | $-92,626 | $-74,847 | $-278 | $-40 | $-39 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 89,938 | 89,938 | 89,938 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 64,370 | 10,000 |
| Financing Cash Flow | $89,938 | $89,938 | $89,938 | $64,370 | $10,000 |
| Beginning Cash Position | 53,349 | 53,349 | 53,349 | 0 | N/A |
| End Cash Position | 22,856 | 51,353 | 135,705 | 53,340 | 3,965 |
| Net Cash Flow | $-30,493 | $-1,996 | $82,356 | $53,340 | $3,965 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,805 | -17,087 | -7,304 | -10,980 | -5,996 |
| Capital Expenditure | -333 | -304 | -278 | -44 | -39 |
| Free Cash Flow | -28,138 | -17,391 | -7,582 | -11,024 | -6,035 |